Future biologic treatments for Perthes disease

Area of Science:

• Orthopedics
• Pediatric Orthopedics
• Pharmacological Research

Background:

• Perthes disease (Legg-Calvé-Perthes disease) is a hip disorder affecting children, characterized by avascular necrosis of the femoral head.
• Current standard treatments include physical therapy and surgery, with limited focus on pharmaceutical interventions.
• Recent research aims to understand the disease's pathophysiology to develop targeted treatments.

Purpose of the Study:

• To present an updated pathophysiological model of Perthes disease.
• To review existing and experimental pharmaceutical treatment strategies.
• To identify promising future research avenues for Perthes disease therapy.

Main Methods:

• Literature review of pathophysiological studies and experimental pharmaceutical treatments for Perthes disease.
• Analysis of current research trends focusing on antiresorptive, anti-inflammatory, revascularization, and anabolic strategies.
• Synthesis of information to propose a current pathophysiological model and future research directions.

Main Results:

• The article outlines a current pathophysiological model for Perthes disease.
• It reviews various experimental pharmaceutical approaches, including antiresorptive, anti-inflammatory, and anabolic strategies.
• The review highlights the potential of targeting inflammation and promoting bone formation.

Conclusions:

• Novel pharmaceutical strategies offer promising alternatives to traditional treatments for Perthes disease.
• Further research into controlling inflammation, enhancing revascularization, and promoting bone formation is warranted.
• A deeper understanding of Perthes disease pathophysiology can guide the development of effective drug-based therapies.